blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3665286

EP3665286 - CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.07.2024
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  11.08.2023
FormerGrant of patent is intended
Status updated on  21.05.2023
FormerExamination is in progress
Status updated on  02.04.2021
FormerRequest for examination was made
Status updated on  15.05.2020
FormerThe international publication has been made
Status updated on  16.02.2019
Formerunknown
Status updated on  20.08.2018
Most recent event   Tooltip19.07.2024No opposition filed within time limitpublished on 21.08.2024  [2024/34]
Applicant(s)For all designated states
Global Life Sciences Solutions Operations UK Ltd
19 Jessops Riverside
800 Brightside Lane
Sheffield
S9 2RX / GB
[2021/21]
Former [2020/25]For all designated states
General Electric Company
1 River Road
Schenectady, NY 12345 / US
Inventor(s)01 / KVAM, Erik, Leeming
GE Global Research
One Research Circle
Niskayuna, New York 12309 / US
02 / NELSON, John, Richard
GE Global Research
One Research Circle
Niskayuna, New York 12309 / US
03 / GAO, Wei
GE Global Research
One Research Circle
Niskayuna, New York 12309 / US
 [2020/25]
Representative(s)Bannan, Sally
Cytiva
Amersham Place
Little Chalfont
Buckinghamshire HP7 9NA / GB
[2023/37]
Former [2020/25]Aldenbäck, Ulla Christina
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
Application number, filing date18752135.606.08.2018
[2020/25]
WO2018EP71229
Priority number, dateUS20171563151011.08.2017         Original published format: US201715631510
[2020/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019030155
Date:14.02.2019
Language:EN
[2019/07]
Type: A1 Application with search report 
No.:EP3665286
Date:17.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 14.02.2019 takes the place of the publication of the European patent application.
[2020/25]
Type: B1 Patent specification 
No.:EP3665286
Date:13.09.2023
Language:EN
[2023/37]
Search report(s)International search report - published on:EP14.02.2019
ClassificationIPC:C12P21/02, C12N15/67, C12P21/00
[2023/22]
CPC:
C12P21/02 (EP,KR,US); C12P21/00 (US); C12P19/34 (KR,US)
Former IPC [2020/25]C12N15/67, C12P21/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/25]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZELLFREIE PROTEINEXPRESSION UNTER VERWENDUNG VON DOPPELSTRÄNGIGER KONKATAMER-DNA[2020/25]
English:CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA[2020/25]
French:EXPRESSION ACELLULAIRE DE PROTÉINES À L'AIDE D'ADN CONCATÉMÈRE À DOUBLE BRIN[2020/25]
Entry into regional phase16.01.2020National basic fee paid 
16.01.2020Designation fee(s) paid 
16.01.2020Examination fee paid 
Examination procedure16.01.2020Examination requested  [2020/25]
16.01.2020Date on which the examining division has become responsible
22.09.2020Amendment by applicant (claims and/or description)
01.04.2021Despatch of a communication from the examining division (Time limit: M06)
05.10.2021Reply to a communication from the examining division
22.05.2023Communication of intention to grant the patent
07.08.2023Fee for grant paid
07.08.2023Fee for publishing/printing paid
07.08.2023Receipt of the translation of the claim(s)
Opposition(s)14.06.2024No opposition filed within time limit [2024/34]
Fees paidRenewal fee
19.08.2020Renewal fee patent year 03
13.08.2021Renewal fee patent year 04
15.06.2022Renewal fee patent year 05
14.06.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT13.09.2023
CZ13.09.2023
DK13.09.2023
EE13.09.2023
FI13.09.2023
HR13.09.2023
LT13.09.2023
LV13.09.2023
PL13.09.2023
RO13.09.2023
RS13.09.2023
SK13.09.2023
SM13.09.2023
NO13.12.2023
GR14.12.2023
IS13.01.2024
PT15.01.2024
[2024/33]
Former [2024/25]AT13.09.2023
CZ13.09.2023
EE13.09.2023
FI13.09.2023
HR13.09.2023
LT13.09.2023
LV13.09.2023
PL13.09.2023
RO13.09.2023
RS13.09.2023
SK13.09.2023
SM13.09.2023
NO13.12.2023
GR14.12.2023
IS13.01.2024
PT15.01.2024
Former [2024/23]AT13.09.2023
CZ13.09.2023
EE13.09.2023
FI13.09.2023
HR13.09.2023
LT13.09.2023
LV13.09.2023
RO13.09.2023
RS13.09.2023
SK13.09.2023
SM13.09.2023
NO13.12.2023
GR14.12.2023
IS13.01.2024
PT15.01.2024
Former [2024/20]FI13.09.2023
HR13.09.2023
LT13.09.2023
LV13.09.2023
RS13.09.2023
SM13.09.2023
NO13.12.2023
GR14.12.2023
IS13.01.2024
Former [2024/11]FI13.09.2023
HR13.09.2023
LT13.09.2023
LV13.09.2023
RS13.09.2023
NO13.12.2023
GR14.12.2023
Former [2024/09]FI13.09.2023
LT13.09.2023
NO13.12.2023
GR14.12.2023
Former [2024/08]LT13.09.2023
NO13.12.2023
GR14.12.2023
Cited inInternational search[YP]WO2017191007  (GEN ELECTRIC [US], et al) [YP] 13-27 * Whole document, especially example 3 and the claims. *;
 [YA]  - NAOKO ABE ET AL, "Rolling Circle Translation of Circular RNA in Living Human Cells", SCIENTIFIC REPORTS, (20151110), vol. 5, no. 1, doi:10.1038/srep16435, XP055511341 [Y] 13-27 * the whole document * [A] 1-12

DOI:   http://dx.doi.org/10.1038/srep16435
 [A]  - GYANENDRA KUMAR ET AL, "Cell-free protein synthesis using multiply-primed rolling circle amplification products", BIOTECHNIQUES RAPID DISPATCHES, US, (20090701), vol. 47, no. 1, doi:10.2144/000113171, ISSN 0736-6205, pages 637 - 639, XP055380979 [A] 1-27 * the whole document *

DOI:   http://dx.doi.org/10.2144/000113171
 [A]  - JUN LI ET AL, "Improved Cell-Free RNA and Protein Synthesis System", PLOS ONE, (20140902), vol. 9, no. 9, doi:10.1371/journal.pone.0106232, page e106232, XP055377617 [A] 1-27 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.pone.0106232
 [A]  - GAGOSKI DEJAN ET AL, "Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems", JOURNAL OF BIOTECHNOLOGY, ELSEVIER, AMSTERDAM, NL, (20141219), vol. 195, doi:10.1016/J.JBIOTEC.2014.12.006, ISSN 0168-1656, pages 1 - 7, XP029221969 [A] 1-27 * abstract *

DOI:   http://dx.doi.org/10.1016/j.jbiotec.2014.12.006
by applicant   - SINGH, S. K., Chem. Comm., (19980000), vol. 4, pages 455 - 456
    - KOSHKIN, A. A., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.